Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study.
Dragana NikolicAngelo M PattiRosaria V GiglioRoberta ChianettaGiuseppa CastellinoAntonio Magán-FernándezRoberto CitarrellaNikolaos PapanasAndrej JanezAnca Pantea StoianAli A RizviManfredi RizzoPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
ClinicalTrials.gov identifier, NCT01715428.